more general categories
information about this item
03. Biological Effects of Specific Chemicals
03. Biological Effects of Specific Chemicals
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
08. Chemical Category
08. Chemical Category
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide [CHEBI:10099] (1)
ChEBI Compound Accession Identifier :
[CHEBI:10099]
ChEBI Compound Description :
The dipeptide obtained by coupling N-benzyloxycarbonyl-L-tyrosine with the hydroxamic acid derivative of L-leucine. It is an inhibitor of the metallo-protease enzyme, pseudolysin (EC 3.4.24.36).
ChEBI Compound Identification Number :
10099
ChEBI InChI Value :
InChI=1S/C23H29N3O6/c1-15(2)12-19(22(29)26-31)24-21(28)20(13-16-8-10-18(27)11-9-16)25-23(30)32-14-17-6-4-3-5-7-17/h3-11,15,19-20,27,31H,12-14H2,1-2H3,(H,24,28)(H,25,30)(H,26,29)/t19-,20-/m0/s1
ChEBI InChIKey Value :
YBHTVSIBHATTHP-PMACEKPBSA-N
ChEBI Compound Name :
N-[(benzyloxy)carbonyl]-L-tyrosyl-N-hydroxy-L-leucinamide
ChEBI SMILES Value :
CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)OCc1ccccc1)C(=O)NO
ChEBI Substance ID :
92740962
ChEBI URL :
ChEBI:10099
ChemSpider ID :
NS
Ontomatica Chemical Accession Key (OnChAKey) :
YBHTVSIBHATTHP_PMACEKPBSA_N_000_000000
PubChem Compound ID :
45266500